Ziliprol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ziliprol

Ziliprol is a pharmaceutical preparation defined by the active ingredient Diclofenac, a substance belonging to the official therapeutic class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). It is a synthetic, small molecule chemically structured as a phenylacetic acid derivative.

Property Description
Active ingredient Diclofenac (e.g., Diclofenac sodium or potassium)
Form Tablet, Capsule, Gel, Solution, Patch (Varies)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief of pain, inflammation, and fever
Origin Synthetic, Phenylacetic acid derivative

What Type of Medicine is Ziliprol and What is its Composition?

Ziliprol's classification as an NSAID means it functions primarily as a Cyclooxygenase (COX) inhibitor. The core medicine, Diclofenac, is typically formulated using salt forms like Diclofenac sodium or Diclofenac potassium to enhance stability. Diclofenac is recognized as a potent inhibitor of both COX-1 and COX-2 enzymes. This confirms that the medicine is established in its ability to reduce inflammation by blocking the specific chemical pathways that trigger swelling and discomfort.

As an INN-based product, the composition is generally a single-active ingredient, available in diverse dosage forms including oral tablets, capsules, and topical preparations like gels and transdermal patches. These forms allow for various routes of administration, such as oral or dermal application, depending on the specific product format.


What is the General Therapeutic Purpose of Ziliprol?

Its core purpose is to interrupt the body’s inflammatory cycle, thereby counteracting the associated physical symptoms. By inhibiting the production of prostaglandins, Ziliprol provides a simultaneous anti-inflammatory effect, a non-narcotic analgesic (pain-relieving) effect, and an antipyretic (fever-reducing) effect. This function positions the medicine as a reliable agent for managing discomfort stemming from inflammatory states.

What side effects are possible with Ziliprol?

Possible Side Effects and Safety Information

This information is based strictly on documentation from government regulatory agencies (e.g., FDA, EMA) and summarizes the officially recognized risks associated with Ziliprol.


Serious and Clinically Significant Risks

Regulatory authorities classify several risks by System-Organ-Class as serious and potentially life-threatening. These include major cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke, and serious gastrointestinal events, including bleeding, ulceration, and perforation of the stomach or intestines. Serious hepatotoxicity (liver damage/failure) and renal toxicity (kidney damage, acute kidney failure, papillary necrosis) are also documented. Additionally, cases of anaphylactic reactions and severe, sometimes fatal, serious skin reactions (e.g., Stevens-Johnson Syndrome) have been officially reported.


Common Adverse Reactions

The most common adverse reactions, typically reported in at least 1% of patients during clinical trials, often involve the gastrointestinal and nervous systems. These frequency-classified events include effects such as dyspepsia and dizziness.


Safety Restrictions and Vulnerable Populations

Ziliprol is contraindicated for pain management immediately following Coronary Artery Bypass Graft (CABG) surgery. It is also not recommended for use in late pregnancy due to the risk of fetal toxicity, specifically the premature closure of the fetal ductus arteriosus and potential renal issues. Elderly patients may face an increased risk of developing serious cardiovascular and gastrointestinal adverse events. The risk of serious gastrointestinal and cardiovascular events is also generally documented to increase with higher doses and longer duration of use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope

Official regulatory information for a product named Ziliprol is not readily available in standard authoritative drug databases. The information below is based on regulatory communications concerning the structurally related substance Zipeprol, an opioid with hallucinogenic properties, and general overdose guidance for its pharmacological class.

Classification Official Regulatory Context
Documented Presentations Reports of overdoses, seizures, hallucinations, and deaths are associated with the chemically similar compound, Zipeprol, according to regulatory documents from the Drug Enforcement Administration (DEA).
Affected Systems Due to its opioid properties, the central nervous system, particularly the respiratory system, is at risk.
Overdose Risk Factors For related extended-release products, a greater risk for overdose and death exists due to the larger total amount of drug present in the formulation.

Required Emergency Action

Immediate medical help is required for any suspected overdose or if signs of severe toxicity occur. Authoritative guidance for similar drug classes explicitly states to seek emergency medical help or call 911 immediately if symptoms of life-threatening respiratory problems are observed.

Symptoms that indicate a medical emergency for similar substances include:

  • Slowed, shallow, or difficult breathing
  • Severe sleepiness or sedation
  • Not being able to respond or wake up

Due to the documented association with severe adverse events, including death, in regulatory records for similar compounds, any suspected exposure beyond therapeutic use should be treated with the utmost urgency and reported to emergency services immediately. The goal of emergency action is to reverse or mitigate severe central nervous system and respiratory depression.

Therapeutic Uses of Ziliprol

What Ziliprol Treats: Main Uses and Benefits

Ziliprol is commonly used in clinical settings that involve acute or unstable symptom patterns, providing supportive symptomatic relief across several key therapeutic areas. It is relevant in conditions characterized by periods of heightened symptoms, such as chronic inflammatory disorders like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. The medication is also applied to ease symptoms that create noticeable functional strain in acute scenarios, including pain from minor trauma, postoperative discomfort, and intense episodic manifestations like migraines and primary dysmenorrhea.


The medication helps address symptom clusters that may become intense or disruptive, such as pain, fever, and swelling. This supports the patient during difficult episodes by easing distress and may help patients cope more steadily with symptom fluctuations.

“It is commonly used to help with symptoms related to physical discomfort and inflammatory or irritative states.”


Quick Fact: Symptomatic Relief for Discomfort and Irritation
Acute Contexts: Relevant when symptoms intensify, such as during episodes of migraine headache or post-injury discomfort.
Chronic Support: Contributes to improved comfort during periods of heightened symptoms of chronic joint stiffness and recurrent pain.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

The eligibility profile for Ziliprol (Diclofenac) is strictly determined by official regulatory criteria, defining specific populations who must not use the medicine.

Who Must Not Use Ziliprol

Ziliprol is contraindicated in patients with a known hypersensitivity to the drug or any other NSAID, including those with a history of asthma, hives, or allergic reactions after taking aspirin. Use is absolutely prohibited in the setting of Coronary Artery Bypass Graft (CABG) surgery and for individuals with active gastrointestinal (GI) ulceration, bleeding, or perforation.

Age and Physiological Restrictions

  • Children: Safety and effectiveness have not been established for most formulations in children under 12 years of age.
  • Pregnancy: The medicine is contraindicated for pregnant women starting at 30 weeks gestation and later.

Conditional Use Limitations

Patients with established cardiovascular conditions, such as severe heart failure or ischaemic heart disease, or those with advanced renal disease must generally avoid use unless the benefits are strictly deemed to outweigh the risks by a qualified professional. Older adults also require caution due to a greater risk for serious GI events.

What should I know about interactions with other medicines?

Ziliprol Interactions with other medicines and products

Official regulatory information for Ziliprol (Diclofenac) identifies several categories of clinically significant interactions with other medicinal products and substances.

Contraindicated Combinations

Ziliprol is strictly contraindicated for co-administration in specific scenarios as defined by prescribing information:

  • Other NSAIDs (including Aspirin): Prohibited due to an additive risk of serious gastrointestinal events and in patients with a history of specific hypersensitivity reactions.
  • CABG Surgery: Contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft surgery.
  • Third Trimester of Pregnancy: Prohibited due to the risk of cardiopulmonary toxicity to the fetus.

Pharmacokinetic and Pharmacodynamic Effects

Interacting Substance/Class Official Interaction Description
Voriconazole Increases Ziliprol systemic exposure (Cmax and AUC) through CYP enzyme inhibition.
Anticoagulants/SSRIs Increases the risk of serious bleeding events due to interference with hemostasis.
Antihypertensives/Diuretics Ziliprol may reduce the therapeutic effect of these medicines.
ACE Inhibitors/Angiotensin II Antagonists Risk of further deterioration of renal function, especially in compromised patients.
Oral Hypoglycemic Agents Potential to prolong the half-life of sulfonylurea drugs by inhibiting their metabolism.

Other Documented Cautions

  • Alcohol: Consumption significantly increases the risk of serious gastrointestinal problems, including bleeding.
  • Elderly or Renal-Compromised Patients: Require particular caution due to heightened susceptibility to adverse renal and gastrointestinal interaction risks.

Mechanism of Action

How Ziliprol Works

Ziliprol's action is defined by its interference with the body's eicosanoid synthesis pathway, targeting the enzymes responsible for generating specific inflammatory mediators.

Mechanism of Action: Prostaglandin Synthesis Cascade Inhibition

This mechanism operates by the active ingredient, Diclofenac, acting as a reversible inhibitor of the Cyclooxygenase (COX-1 and COX-2) enzymes. By competitively blocking the conversion of Arachidonic Acid, this action directly suppresses the production of Prostaglandins ( PGE2 and PGI2). This suppression modifies early molecular steps that shape systemic physiological outcomes by reducing the concentration of mediators responsible for initiating heightened responses.

Action on Peripheral Nociceptive Signaling and Thermoregulation

The resulting reduction in Prostaglandins engages mechanisms that modulate overactive processes in two key systems. Peripherally, it decreases the sensitization of nociceptive neurons (nociceptors), resulting in a dampened signaling state within the pathway. Centrally, the mechanism operates in the hypothalamus to prevent PGE2-induced elevation of the body's thermoregulatory set point. This simultaneous dual action leads to observable physiological adjustments that contribute to the drug’s overall effect profile.

Dosage and Administration Information

How Ziliprol is Used: Official Administration Guidelines

Ziliprol, containing the active ingredient Diclofenac, is administered according to the principle of using the lowest effective dosage for the shortest possible duration. Its official use is defined by the specific dosage form and route of administration.


Administration Routes and Standard Dosing

The medicine is approved for Oral, Topical (dermal), Intramuscular (IM), Intravenous (IV), and Rectal administration, depending on the specific formulation. Oral doses are often given in divided regimens, typically two to four times daily. For instance, the general maximum daily dose for some oral delayed-release tablets is 150 mg for osteoarthritis and 200 mg for rheumatoid arthritis.


Procedural Rules and Timing

Administration conditions are strictly defined in official labeling. Delayed-release and extended-release tablets must be swallowed whole and not crushed or chewed. Certain immediate-release forms, such as the powder for oral solution, require mixing with water only and should be taken on an empty stomach to optimize use.

For topical use, such as the 1% gel, it is administered four times a day (q.i.d.) and must be measured accurately using the provided dosing card. In older adults, it is a consistent instruction to start at the lowest effective dose.

If a dose is missed, patients are officially instructed to skip the missed dose if the next scheduled dose is near, and not to double the dose to compensate.

Recent Clinical Evidence

Ziliprol: Recent Clinical Evidence

Evidence for Use in Chronic Joint Pain (Osteoarthritis, Rheumatoid Arthritis, and Spondylitis)

Research exploring the use of Ziliprol in conditions like Osteoarthritis is supported by a large foundation of evidence, primarily consisting of Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time and how they compare to placebo treatments. The studies monitored adult populations, including the elderly, who were experiencing conditions marked by functional limitations and periods of heightened symptoms. Studies reported patterns in the measurement of pain and daily functioning scores, where mean reported scores were different when the medicine was administered compared to the control group. This research highlights changes measured during the short-term study period, typically lasting between 6 and 12 weeks. Findings were sometimes mixed regarding measurements of functional outcomes in certain joint locations or with specific formulations.

Evidence for Use in Acute Pain and Episodic Conditions

Ziliprol was evaluated in studies designed to assess its role in managing temporary physiological imbalance associated with sudden, intense discomfort. These trials are relevant in studies examining short-term or episodic symptom patterns, such as pain following minor trauma, post-operative discomfort, or intense, acute episodes like migraine attacks and primary dysmenorrhea. Studies reported patterns in the timing of symptom measurement, where the use of the medicine was associated with earlier reported changes and a longer interval before rescue medication was requested compared to control groups. Data for certain groups remain insufficient, and research exploring short-term symptom changes does not determine whether an individual will respond similarly.

Long-Term Research and Study Durations

The majority of the controlled efficacy studies for Ziliprol investigated symptom changes over defined time intervals of a relatively short duration. For chronic conditions like Osteoarthritis, the primary studies often had follow-up durations that were limited to 6 to 12 weeks. Research describes that patients who were included in follow-up were sometimes observed in subsequent open-label extension studies over longer periods, sometimes up to a year. However, these longer observational studies do not offer the same level of certainty as the original controlled RCTs.

What Remains Uncertain in the Research Landscape

The evidence highlights what is known—and what is still uncertain. Long-term effects are not fully established for all formulations, and there is limited information regarding the durability of symptom relief over multiple years. Comparative evidence against other available treatments is lacking. Subgroup findings are uncertain, meaning there is less available research detailing the specific performance of the medicine in patients with complex comorbidities or very advanced stages of certain chronic conditions.

Key Studies & References Diclofenac: General Overview and Therapeutic Uses (NIH StatPearls)

Frequently Asked Questions (FAQ)

Common questions about Ziliprol (FAQ)


Q: Is Ziliprol meant to be taken for a long period of time?

Official guidance for Ziliprol is to use the lowest effective dosage for the shortest possible duration that is consistent with the goals of individual treatment. While the medicine is used for managing conditions that may involve chronic use, this principle is described in the official guidance.


Q: Are the side effects of Ziliprol usually mild?

The official labeling for Ziliprol lists both common adverse reactions, such as dizziness or dyspepsia (indigestion), and serious, potentially life-threatening risks. Official information indicates the presence of both categories of effects.


Q: Is Ziliprol safe for older people, generally speaking?

Official documents note that older adults are described as having an increased potential for serious adverse events (including cardiovascular and gastrointestinal risks) compared to younger adults. Treatment for this population is often managed by starting at the lowest effective dose.


Q: How does Ziliprol affect other long-term medical conditions?

Official information describes circumstances where use is contraindicated or subject to conditional use limitations in patients with established long-term conditions. This includes severe heart failure, ischaemic heart disease, and advanced renal (kidney) disease, due to heightened risk profiles.


Q: How quickly does Ziliprol usually start to have an effect?

Official regulatory studies describing how quickly the medicine works show variability based on the specific formulation. For certain forms used to treat acute pain, studies reported that the median duration of the analgesic (pain-relieving) effect was approximately 6 hours for patients who experienced a positive response.


Q: Do many people stop taking Ziliprol because of side effects?

Some official safety reviews describe instances of patient discontinuation related to specific adverse events. For instance, data from some reviews focusing on liver health indicate that liver-related discontinuation occurred in a specific proportion of patients, such as 1.8 per 100 patient-years in one analysis.


Q: Are there any major diet restrictions while taking Ziliprol?

Official regulatory documents do not list any major food or dietary restrictions while taking Ziliprol. While food may influence the absorption rate of some oral forms, official studies indicate it does not significantly affect the total amount of drug exposure (AUC) in the body.


Q: What does it mean if Ziliprol interacts with another medicine?

A drug interaction is a reaction between Ziliprol and another medicine or substance that can alter how Ziliprol acts in the body. This change can potentially alter its effectiveness or its safety profile, according to official information.


Q: What are the warnings about mixing Ziliprol with other supplements?

Official information describes that a discussion with a healthcare professional is typically needed before mixing the medicine with herbal remedies or supplements. This caution is due to the fact that there may be insufficient information available to confirm safety.


Q: Is there a version of Ziliprol available that is a generic?

Yes, regulatory databases list formulations of the active ingredient, Diclofenac, with an Abbreviated New Drug Application (ANDA) marketing status. This status indicates that generic versions are approved for sale by the relevant regulatory bodies.


Q: Why is Ziliprol sometimes taken off the market in certain countries?

Regulatory actions like restricting availability or updating warnings have been taken in some jurisdictions following safety reviews. These reviews identified increased risks of serious cardiovascular events when compared to certain other nonsteroidal anti-inflammatory drugs (NSAIDs).


Q: What should I do if I am traveling with Ziliprol?

Government travel authorities generally advise keeping the medicine in its original container with the dispensing label for travel. They also recommend carrying a copy of the valid prescription or a doctor's note and traveling with no more than a personal use supply.


Q: Does taking Ziliprol cause people to gain or lose weight?

Regulatory documentation lists weight changes as a possible adverse effect under the Metabolic and Nutritional system. Regulatory documents list both unusual weight gain and weight loss as possible adverse effects observed in some patients.


Q: Is it true that Ziliprol can affect sleep patterns?

Yes, the official adverse reaction profile includes nervous system effects that can affect sleep. These are documented to include side effects such as insomnia, drowsiness, and dream abnormalities.


Q: Is Ziliprol available over the counter anywhere?

Yes, some lower-strength formulations of Ziliprol, such as the 1% gel, have been approved by the FDA to switch from prescription status to non-prescription (Over-the-Counter) status for patient use.


Q: Does Ziliprol have a black box warning in the US?

Yes, US regulatory documents contain a Boxed Warning (sometimes called a 'Black Box Warning') that highlights the risk of serious cardiovascular thrombotic events (like heart attack or stroke) and gastrointestinal events (like bleeding or perforation).


Q: Can Ziliprol change the results of blood tests?

The medicine is documented to cause potential hepatotoxicity and renal toxicity; therefore, official documents describe that monitoring of liver and kidney function tests is often required during use.


Q: Is Ziliprol a controlled substance?

No, the medicine is not classified as a controlled substance by the Drug Enforcement Administration (DEA).


Q: Can Ziliprol cause mood changes or mental health side effects?

Yes, the adverse reaction profile lists potential nervous system and psychiatric effects. These have been documented to include effects such as confusion, depression, anxiety, and irritability.


Q: What is the half-life of Ziliprol described as in studies?

Regulatory documents describe the terminal half-life of the unchanged active ingredient in the plasma as approximately 1 to 2.3 hours.


How should Ziliprol be stored and disposed of?

Regulatory documents specify that Ziliprol (Diclofenac) must be stored under conditions that maintain its labeled stability. The medicine is required to be stored at Controlled Room Temperature, which is generally 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C (86 F).

The product must be protected from heat, moisture, and direct light [1.3] and kept in a tightly closed container [1.3]. It is mandatory to keep this medicine out of the sight and reach of children at all times [2.4].

For disposal of unused or expired product, the official guidance prioritizes drug take-back programs or mail-back envelopes [2.4]. If these options are unavailable, the medicine must be mixed with an undesirable substance (e.g., used coffee grounds) and sealed in a container before being placed in household trash [2.4]. Disposal must avoid entering drains or the sewage system [2.1].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ziliprol found in:

A-Z Index: